A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts

Transplantation

Volumn 72, Issue 1, 2001, Pages 44-51

  Wang, Chuanmin ^a   Sun, Junhong ^a   Sheil, A G Ross ^a   McCaughan, Geoffrey W ^a   Bishop, G Alex ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; NICK END LABELING; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

ANIMALS; APOPTOSIS; CELL MOVEMENT; DRUG ADMINISTRATION SCHEDULE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; LIVER; LIVER TRANSPLANTATION; MALE; METHYLPREDNISOLONE; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; SPLEEN; TISSUE DONORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035879615     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107150-00011     Document Type: Article

References (26)

1. Induction of immunological tolerance by porcine liver allografts
2. Orthotopic liver allografts in the rat: The influence of strain combination on the fate of the graft
3. Orthotopic liver transplantation in the mouse
4. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclona antibody
5. Liver transplants contribute to their own success
6. High dose/activation-associated tolerance: A mechanism for allograft tolerance
7. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA
8. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues
9. Differential effects of cyclosporine A, methylprednisolone, mycophenolate and rapamycin on CD154 induction and requirement for NFκB
10. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation
11. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure
12. Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients
13. A surgical experience with 530 liver transplants in the rat
14. Tolerance to rat liver allografts 1. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response
15. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
16. Weaning of immunosuppression in long-term liver transplant recipients
17. Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression
18. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
19. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
20. Kinetics of intragraft cytokine expression, cellular infiltration and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: Early activation and apoptosis is associated with liver graft acceptance
21. Inhibition of T cell proliferation by macrophage tryptophan catabolism
22. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway
23. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction
24. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance
25. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
26. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance